Bert Vogelstein

Molecular Biology · 2000–2022

A researcher in the Science corpus: 53 papers; trusts 13 researchers and is trusted by 28 researchers here, as inferred from the citation graph.

Subfields

Molecular Biology — 306 citations into it; #2,758 of 17,773 by trust here, #132 by citations
Oncology — 162 citations into it; #312 of 1,698 by trust here, #30 by citations
Cancer Research — 143 citations into it; #193 of 1,780 by trust here, #18 by citations
Genetics — 124 citations into it; #2,814 of 6,854 by trust here, #124 by citations
Pathology and Forensic Medicine — 61 citations into it; #81 of 414 by trust here, #3 by citations
Statistics and Probability — 7 citations into it
Artificial Intelligence — 6 citations into it
Computer Vision and Pattern Recognition — 6 citations into it

Whom Bert Vogelstein trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts Bert Vogelstein overall

Papers from Bert Vogelstein's perspective

Ordered by how strongly the researchers Bert Vogelstein trusts endorse each paper. Same corpus, a different order for every researcher.

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
Comparative lesion sequencing provides insights into tumor evolution (Proceedings of the National Academy of Sciences of the United States of America)
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
A CENSUS OF HUMAN CANCER GENES (Nature Reviews. Cancer)
IDH1 and IDH2 mutations in gliomas. (New England Journal of Medicine)
Genetic basis for clinical response to CTLA-4 blockade in melanoma. (New England Journal of Medicine)
The PIK3CA gene is mutated with high frequency in human breast cancers (Cancer Biology & Therapy)
BLAT--the BLAST-like alignment tool. (Genome Research)
Highly recurrent TERT promoter mutations in human melanoma (Science)
Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)

Their papers

The Consensus Coding Sequences of Human Breast and Colorectal Cancers (2006) — 2,786 citations
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (2008) — 4,022 citations
An Integrated Genomic Analysis of Human Glioblastoma Multiforme (2008) — 5,476 citations
The colorectal microRNAome. (2006) — 999 citations
Cancer Genome Landscapes (2013) — 7,218 citations
High Frequency of Mutations of the PIK3CA Gene in Human Cancers (2004) — 3,682 citations
Cancer genes and the pathways they control (2004) — 4,411 citations
The Genomic Landscapes of Human Breast and Colorectal Cancers (2007) — 2,499 citations
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells (2002) — 1,301 citations
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells (2009) — 936 citations
Cancer-specific High-throughput Annotation of Somatic Mutations: computational prediction of driver missense mutations (2009) — 457 citations
Mutant PIK3CA promotes cell growth and invasion of human cancer cells. (2005) — 938 citations
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal (2013) — 1,326 citations
Evaluating the evaluation of cancer driver genes (2016) — 352 citations
Role of BAX in the apoptotic response to anticancer agents. (2000) — 947 citations
The genetic landscape of the childhood cancer medulloblastoma (2010) — 734 citations
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma (2010) — 1,258 citations
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations (2003) — 830 citations
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 (2011) — 1,798 citations
PUMA mediates the apoptotic response to p53 in colorectal cancer cells (2003) — 617 citations